The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...

During Fast Company and Johns Hopkins University’s World Changing Ideas Summit last November, we asked leaders what are the ...

Explore The Innovation Antibody and how organizational resistance can kill innovation from within, undermining growth, adaptability, and long-term competitiveness in rapidly changing markets The ...

New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

Tharimmune (THAR) builds a Canton Coin digital asset treasury with $545 million raised. Read here for a detailed investment ...

Standardized monitoring workflows and clearer reimbursement support are critical to improving community clinicians’ readiness ...

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...